跳至主要内容
临床试验/NCT01547533
NCT01547533已完成不适用

Study of Benznidazole Transfer Into Breastmilk in Lactating Women Treated for Chagas Disease

Hospital de Niños R. Gutierrez de Buenos Aires1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2011年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
1
主要终点
Benznidazole concentration in breastmilk and in plasma

研究概览

简要总结

The investigators propose to study the transfer of benznidazole into breastmilk from the blood of lactating women who receive the drug for the treatment of Chagas disease. Breastmilk and blood samples will be obtained from these patients at given times after they take the clinically indicated medication, and the concentrations in both matrices will be compared to estimate degree of transfer, which in turn will be used to evaluate potential degree of exposure of infants breastfed by these women. This study will help clarify safety of continuing breastfeeding while receiving treatment with benznidazole for Chagas disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Lactating women with Chagas disease, not treated before
  • Use of contraception

排除标准

  • History of allergy to benznidazole or its excipients
  • Pregnancy
  • Significant heart involvement (due to Chagas disease)
  • Significant systemic diseases that could affect the interpretation of the results in the opinion of the principal investigator

结局指标

主要结局

Benznidazole concentration in breastmilk and in plasma

时间窗: at randomly selected time points during the 30 days of treatment

Randomly obtained breastmilk samples will be obtained to both evaluate the breastmilk / plasma concentration ratio of the drug, and to develop a population pharmacokinetics model of drug trasfer into breastmilk, if possible. Breastmilk concentrations will be used to calculate potential infant exposure through breastmilk to the medication (benznidazole) taken by the mother

次要结局

  • incidence of adverse drug reactions in women treated with benznidazole during lactation(throughout the 30 days of treatment)

研究者

发起方
Hospital de Niños R. Gutierrez de Buenos Aires
申办方类型
Other
责任方
Principal Investigator
主要研究者

Facundo Garcia-Bournissen

Associate Researcher

Hospital de Niños R. Gutierrez de Buenos Aires

研究点 (1)

Loading locations...

相似试验